Home / Recalls / Medical Devices
Hospira Inc. recalls The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, elect
Recalled August 7, 2013 · FDA recall Z-1847-2013 · Hospira
Hazard
The devices secondary audio signal fails to activate. · FDA Class II
Units
2,791 units
Sold at
US Distribution including the states of AL, CA, CT, DE, FL, HI, IA, IL, IN, LA, MA, MD, ME, MI, MN, NC, NJ, NY, PA, SD, TX and WA.
Description
The devices secondary audio signal fails to activate.
Product
The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →